Growth Metrics

Medpace Holdings (MEDP) Capital Expenditures (2016 - 2026)

Medpace Holdings filings provide 12 years of Capital Expenditures readings, the most recent being $6.8 million for Q1 2026.

  • On a quarterly basis, Capital Expenditures fell 31.82% to $6.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $28.2 million, a 31.35% decrease, with the full-year FY2025 number at $31.4 million, down 14.21% from a year prior.
  • Capital Expenditures hit $6.8 million in Q1 2026 for Medpace Holdings, up from $4.5 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $12.9 million in Q2 2024 to a low of $4.5 million in Q4 2025.
  • Median Capital Expenditures over the past 5 years was $9.2 million (2022), compared with a mean of $8.7 million.
  • Biggest five-year swings in Capital Expenditures: soared 86.42% in 2022 and later tumbled 52.51% in 2025.
  • Medpace Holdings' Capital Expenditures stood at $9.2 million in 2022, then increased by 8.04% to $10.0 million in 2023, then decreased by 23.46% to $7.6 million in 2024, then crashed by 40.65% to $4.5 million in 2025, then soared by 50.22% to $6.8 million in 2026.
  • The last three reported values for Capital Expenditures were $6.8 million (Q1 2026), $4.5 million (Q4 2025), and $10.7 million (Q3 2025) per Business Quant data.